Travere Therapeutics Inc (TVTX)
5.45
-0.29
(-5.05%)
USD |
NASDAQ |
Apr 24, 16:00
5.50
+0.05
(+0.92%)
After-Hours: 05:48
Travere Therapeutics Cash and Short Term Investments (Quarterly): 566.85M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 566.85M |
| September 30, 2023 | 634.64M |
| June 30, 2023 | 491.34M |
| March 31, 2023 | 561.51M |
| December 31, 2022 | 450.24M |
| September 30, 2022 | 506.33M |
| June 30, 2022 | 553.17M |
| March 31, 2022 | 603.39M |
| December 31, 2021 | 552.88M |
| September 30, 2021 | 551.18M |
| June 30, 2021 | 522.79M |
| March 31, 2021 | 520.87M |
| December 31, 2020 | 361.59M |
| September 30, 2020 | 456.27M |
| June 30, 2020 | 457.38M |
| March 31, 2020 | 356.46M |
| December 31, 2019 | 398.52M |
| September 30, 2019 | 407.02M |
| June 30, 2019 | 425.90M |
| March 31, 2019 | 447.65M |
| December 31, 2018 | 471.54M |
| September 30, 2018 | 478.81M |
| June 30, 2018 | 255.69M |
| March 31, 2018 | 264.06M |
| December 31, 2017 | 300.63M |
| Date | Value |
|---|---|
| September 30, 2017 | 303.87M |
| June 30, 2017 | 295.98M |
| March 31, 2017 | 248.16M |
| December 31, 2016 | 255.87M |
| September 30, 2016 | 274.30M |
| June 30, 2016 | 221.51M |
| March 31, 2016 | 222.34M |
| December 31, 2015 | 229.60M |
| September 30, 2015 | 235.28M |
| June 30, 2015 | 133.61M |
| March 31, 2015 | 126.33M |
| December 31, 2014 | 27.76M |
| September 30, 2014 | 37.79M |
| June 30, 2014 | 43.44M |
| March 31, 2014 | 5.041M |
| December 31, 2013 | 6.130M |
| September 30, 2013 | 16.37M |
| June 30, 2013 | 0.2865M |
| March 31, 2013 | 2.504M |
| November 30, 2012 | 0.0039M |
| August 31, 2012 | 0.0039M |
| May 31, 2012 | 0.0039M |
| February 29, 2012 | 0.0039M |
| November 30, 2011 | 0.0039M |
| August 31, 2011 | 0.0039M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
356.46M
Minimum
Mar 2020
634.64M
Maximum
Sep 2023
493.60M
Average
506.33M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| AtriCure Inc | 137.28M |
| Bio-Rad Laboratories Inc | 1.607B |
| Artivion Inc | 58.94M |
| Shockwave Medical Inc | 990.55M |
| Perspective Therapeutics Inc | 9.238M |